article thumbnail

Global decentralized studies will become a standard clinical trial design approach

The Pharma Data

After a year of unprecedented disruption in the clinical research industry, 2021 is set to be another transformative year for sponsors and contract research organizations (CROs), according to John Reites, president of Thread, a technology and service provider focusing on decentralized clinical research.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

Cohen says this new infrastructure has been unveiled at Fortrea’s Leeds location in the UK and expanded to a couple of US clinics to include new Current Good Manufacturing Practice (CGMP) pharmacies. This is all done to protect the safety and well-being of research subjects, which is always paramount.

article thumbnail

Common Pitfalls in Preparing an IND Application

Advarra

Using nonclinical data or manufacturing information that doesn’t adequately support the clinical protocol hurts the IND application. It’s critical to ensure all nonclinical data supports the clinical design and provides adequate justification of the desired labeling claims – including basic exposure data.